The women carriers of pathogenic variants (mutations) in the BRCA1 and BRCA2 genes (BRCA1/2) show a very high risk of breast cancer (BC) and/or ovarian cancer (OC) (Kuchenbaecker et al., 2017). Here, BRCA1 is linked to breast carcinoma.